These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33767986)

  • 61. MiR-130 exerts tumor suppressive function on the tumorigenesis of human non-small cell lung cancer by targeting PTEN.
    Ye L; Wang Y; Nie L; Qian S; Xu M
    Am J Transl Res; 2017; 9(4):1856-1865. PubMed ID: 28469790
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MiR-514 attenuates proliferation and increases chemoresistance by targeting ATP binding cassette subfamily in ovarian cancer.
    Xiao S; Zhang M; Liu C; Wang D
    Mol Genet Genomics; 2018 Oct; 293(5):1159-1167. PubMed ID: 29752546
    [TBL] [Abstract][Full Text] [Related]  

  • 63. miR-378a-3p sensitizes ovarian cancer cells to cisplatin through targeting MAPK1/GRB2.
    Xu ZH; Yao TZ; Liu W
    Biomed Pharmacother; 2018 Nov; 107():1410-1417. PubMed ID: 30257357
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1.
    Xu S; Fu GB; Tao Z; OuYang J; Kong F; Jiang BH; Wan X; Chen K
    Oncotarget; 2015 Sep; 6(28):26457-71. PubMed ID: 26238185
    [TBL] [Abstract][Full Text] [Related]  

  • 65. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
    Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H
    Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma.
    Ge T; Liu T; Guo L; Chen Z; Lou G
    Exp Cell Res; 2020 Nov; 396(1):112241. PubMed ID: 32835657
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression.
    Chang S; Chen B; Wang X; Wu K; Sun Y
    BMC Cancer; 2017 Apr; 17(1):248. PubMed ID: 28388883
    [TBL] [Abstract][Full Text] [Related]  

  • 69. miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.
    van Jaarsveld MT; Helleman J; Boersma AW; van Kuijk PF; van Ijcken WF; Despierre E; Vergote I; Mathijssen RH; Berns EM; Verweij J; Pothof J; Wiemer EA
    Oncogene; 2013 Sep; 32(36):4284-93. PubMed ID: 23045278
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2.
    Xing F; Song Z; He Y
    Biol Res; 2018 Nov; 51(1):50. PubMed ID: 30474570
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MicroRNA-208a-3p promotes osteosarcoma progression via targeting PTEN.
    Fu Y; Wang Y; Bi K; Yang L; Sun Y; Li B; Liu Z; Zhang F; Li Y; Feng C; Bi Z
    Exp Ther Med; 2020 Dec; 20(6):255. PubMed ID: 33178353
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Overexpression of NPTX2 Promotes Malignant Phenotype of Epithelial Ovarian Carcinoma
    Han X; Lu Y; Li X; Xia L; Wen H; Feng Z; Ju X; Chen X; Wu X
    Front Oncol; 2021; 11():643986. PubMed ID: 33768003
    [TBL] [Abstract][Full Text] [Related]  

  • 74. FGFR3 phosphorylates EGFR to promote cisplatin-resistance in ovarian cancer.
    Zhao J; Tan W; Zhang L; Liu J; Shangguan M; Chen J; Zhao B; Peng Y; Cui M; Zhao S
    Biochem Pharmacol; 2021 Aug; 190():114536. PubMed ID: 33794187
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy.
    Tchounwou PB; Dasari S; Noubissi FK; Ray P; Kumar S
    J Exp Pharmacol; 2021; 13():303-328. PubMed ID: 33776489
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Type of chemotherapy has substantial effects on the immune system in ovarian cancer.
    Vankerckhoven A; Baert T; Riva M; De Bruyn C; Thirion G; Vandenbrande K; Ceusters J; Vergote I; Coosemans A
    Transl Oncol; 2021 Jun; 14(6):101076. PubMed ID: 33770618
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation.
    Sun J; Zhou C; Zhao Y; Zhang X; Chen W; Zhou Q; Hu B; Gao D; Raatz L; Wang Z; Nelson PJ; Jiang Y; Ren N; Bruns CJ; Zhou H
    Redox Biol; 2021 May; 41():101942. PubMed ID: 33770521
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer.
    Golden E; Rashwan R; Woodward EA; Sgro A; Wang E; Sorolla A; Waryah C; Tie WJ; Cuyàs E; Ratajska M; Kardaś I; Kozlowski P; Johnstone EKM; See HB; Duffy C; Parry J; Lagerborg KA; Czapiewski P; Menendez JA; Gorczyński A; Wasag B; Pfleger KDG; Curtis C; Lee BK; Kim J; Cursons J; Pavlos NJ; Biernat W; Jain M; Woo AJ; Redfern A; Blancafort P
    Nat Commun; 2021 Mar; 12(1):1920. PubMed ID: 33772001
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bibenzyl analogue DS-1 inhibits MDM2-mediated p53 degradation and sensitizes apoptosis in lung cancer cells.
    Putri HE; Nutho B; Rungrotmongkol T; Sritularak B; Vinayanuwattikun C; Chanvorachote P
    Phytomedicine; 2021 May; 85():153534. PubMed ID: 33773191
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effective degradation of EGFR
    Qu X; Liu H; Song X; Sun N; Zhong H; Qiu X; Yang X; Jiang B
    Eur J Med Chem; 2021 Jun; 218():113328. PubMed ID: 33773286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.